Sustained Innovation Suanfarma’s focus on developing innovative pharmaceutical ingredients, including anti-infective API through precision fermentation, highlights opportunities to collaborate on advanced biotechnological projects and high-growth therapeutic categories.

Global Reach With a strong international presence through 12 local offices serving over 400 customers in more than 70 countries, there are significant opportunities to expand sales channels and partner with new clients worldwide.

Strategic Acquisitions The recent acquisition by Archimed Sas and the company’s growth into a recognized leader in nutraceutical ingredients suggest potential for cross-selling complementary products and expanding its service portfolio to existing and new customers.

Collaborative Projects Partnerships with Reyoung Pharmaceutical and Willow Biosciences for developing large volume and anti-infective APIs point to ongoing opportunities to co-develop custom solutions and innovate within specialized therapeutic areas.

Regulatory Excellence All facilities meet the highest regulatory standards, enabling the company to pursue new markets and complex projects which can translate into increased sales of high-quality, compliant pharmaceutical ingredients globally.